Aldesleukin Completed Phase 2 Trials for Multiple Myeloma and Plasma Cell Neoplasm Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00616720Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma